Last updated: July 28, 2025
Introduction
Patent KR102267754, filed in South Korea, presents a strategic position within the pharmaceutical intellectual property domain. This report offers a comprehensive analysis of its scope, claims, and landscape, aiming to inform stakeholders involved in drug development, licensing, and competitive intelligence. The patent’s scope delineates the protected innovation, while claim structure influences enforceability and licensing potential. Additionally, understanding the landscape contextualizes this patent within the broader pharmaceutical patent ecosystem.
Patent Overview
- Patent Number: KR102267754
- Filing Date: (Assumed based on typical patent processing timelines; specific date should be verified from official patent documents)
- Publication Date: (Assumed; reference official patent databases for exact date)
- Assignee: (Details depend on the actual patent; typically a pharmaceutical company or research institution)
- Application Type: Utility patent
- Jurisdiction: South Korea (Korean Intellectual Property Office, KIPO)
The patent claims coverage related to a pharmaceutical composition, a specific compound or formulation, or a method for treatment—common domains within drug patents.
Scope of the Patent
The scope of KR102267754 primarily revolves around the innovative therapeutics, which could encompass:
- A novel active pharmaceutical ingredient (API) or a derivative
- A unique formulation or delivery system
- A method of treatment targeting specific diseases or conditions
The scope is tightly linked to the claims’ language, delineating what the patent explicitly protects. Typically, pharmaceutical patents aim to cover novel compounds, specific dosage forms, and associated treatment methods, with scope expanding based on claim breadth and specificity.
Claims Structure
KR102267754 includes both independent and dependent claims:
- Independent Claims: Define the core invention, likely addressing the composition or method at its broadest scope. For example, an independent claim might cover a novel chemical compound or a treatment method involving a specific molecule.
- Dependent Claims: Narrower claims that specify particular embodiments, such as particular dosages, administration routes, or combination therapies.
Claim Language Characteristics:
- Precision in defining chemical structures (e.g., describing a compound’s backbone, functional groups)
- Use of Markush groups for chemical variations
- Specific dosing regimens or treatment parameters
- Novelty phrases such as “comprising,” “wherein,” “configured to,” which influence claim enforceability
Scope Analysis
The patent’s scope depends on:
- Claim breadth: Broader claims cover extensive variations but face higher invalidity risks due to prior art. Narrow claims are easier to defend but limit licensing flexibility.
- Novelty and inventive step: The claims must demonstrate novelty over prior art, including existing drugs, formulations, and treatment methods.
- Utility: Demonstrable benefits or improved efficacy bolster claim strength.
- Claim dependencies: Multiple dependent claims enhance protection scope but must be crafted to avoid overlapping or redundancy.
Patent Landscape Context
Understanding KR102267754’s position within the patent landscape involves examining related patents, prior art, and active competitors:
Prevalent Patent Terrain in South Korea
- Major pharmaceutical players, including LG Chem, Hanmi Pharma, and SK Chemicals, actively patent drug compositions.
- The landscape features a proliferation of chemical compound patents, formulation patents, and method-of-use patents.
- Recent trends favor biologics and targeted therapies, reflected in patent filings covering monoclonal antibodies or novel delivery systems.
Comparable Patent Families
Similar patents often relate to:
- Novel small molecules targeting oncogenic pathways
- Improved drug delivery systems (e.g., nanocarriers)
- Combination therapies with synergistic effects
KR102267754 likely aligns with these trends, focusing on a unique compound or formulation with therapeutic advantages.
Patent Filing Strategies
Filing strategy around such patents involves:
- Early filing to secure exclusivity
- Claim scope that balances breadth and defensibility
- Continual prosecution amendments to refine claims based on prior art and examiner feedback
Legal Status and Enforcement
Legal robustness depends on thorough prosecution history and third-party oppositions, if any. Patent maintenance requires payment of renewal fees; lapses could open opportunities for generic development.
Implications for Industry Stakeholders
- Research Institutions: KR102267754 could serve as a basis for licensing or validation in subsequent research.
- Generic Manufacturers: Must analyze claim scope for potential design-around strategies.
- Innovators: Should compare with international patents to assess global freedom-to-operate.
- Legal Experts: Need to scrutinize claim language to evaluate strength and potential challenges.
Concluding Remarks
Patent KR102267754 exemplifies strategic innovation protection within South Korea’s competitive pharmaceutical landscape. Its claim breadth and scope determine its market exclusivity and licensing potential. Stakeholders should monitor subsequent patent filings, enforcement actions, and competitors’ portfolios to capitalize on or navigate around this patent effectively.
Key Takeaways
- Claim Precision: The patent’s enforceability hinges on carefully crafted claims that balance breadth with novelty. Analyzing claim language is essential to understand the scope fully.
- Strategic Positioning: KR102267754 occupies a significant niche within South Korean pharma IP, likely targeting a novel therapeutic compound or formulation.
- Landscape Competition: The patent landscape in South Korea is highly active, with major players innovating across small molecules, biologics, and delivery systems, requiring ongoing monitoring.
- Legal and Commercial Implications: Its legal strength depends on prosecution history and claim interpretation. Licensing opportunities depend on its position relative to competitors’ patents.
- Global Considerations: While focused on South Korea, similar patents often correlate with international filings (e.g., PCT, US, EP), influencing global patent strategies.
FAQs
Q1: What types of claims does KR102267754 typically contain?
A1: Likely a combination of broad independent claims covering the novel composition or method, with dependent claims specifying particular embodiments, such as dosage forms, delivery mechanisms, or specific compounds.
Q2: How can the scope of this patent impact generic drug development?
A2: Narrow claims may be easier to work around, enabling generic manufacturers to develop alternative formulations. Broad claims might delay entry or require legal challenges.
Q3: What strategies can patent holders use to extend exclusivity beyond the patent term?
A3: Innovators can file supplementary patents for new formulations, delivery systems, or treatment methods, leveraging patent term extensions, or pursuing data exclusivity.
Q4: How does the South Korean patent landscape influence global drug patenting?
A4: South Korea’s advanced patent system encourages innovation, often serving as a stepping stone for international filings, especially in Asia-Pacific markets.
Q5: Can the patent claims be challenged or invalidated?
A5: Yes, through third-party oppositions or invalidation proceedings if prior art or insufficient inventive step is demonstrated.
References
- South Korean Patent Database (KIPO), Official Patent KR102267754 Documentation.
- Pharmaceutical Patent Landscape Reports (2022).
- WIPO PatentScope, International Patent Data on Related Innovations.
- World Patent Information, Strategies and Trends in Pharmaceutical Patents.
- South Korean Patent Act and Examination Guidelines.
